| Document |
Document Title |
|
WO/2024/096874A1 |
An organic base, including: a solid powder; wherein the solid powder is derived from marine algae; wherein the solid powder is freeze dried; and wherein the solid powder is at least partially water soluble.
|
|
WO/2024/096016A1 |
The present invention provides a polysaccharide-containing particle production method including a spray-drying step and a desalination step, wherein, at the spray-drying step, a dispersion including polysaccharides in salt form is spray-...
|
|
WO/2023/048639A8 |
Disclosed herein is a compound of formula I: A-[B]n-C I where: A represents a peptide group that targets a viral protease, B, when present, represents a self-immolative linking group, C represents a fluorophore or chemilumiphore group co...
|
|
WO/2024/095177A1 |
The present disclosure provides a manganese bifunctional chelating agent conjugation platform for targeted MR imaging. The platform includes an MRI-active manganese porphyrin (MnP) compound connected to a linker which in turn is connecte...
|
|
WO/2024/095351A1 |
Provided is a method for producing polysaccharide-containing particles using a desalting agent. The present invention provides a method for producing polysaccharide-containing particles, the method comprising a spray drying step and a he...
|
|
WO/2024/094911A1 |
The present invention relates to an elastomer material comprising cashew gum and at least another polymer, and a method for obtaining same, based on the electro-hydrodynamic and/or aero-hydrodynamic processing of a previously prepared mi...
|
|
WO/2024/087273A1 |
A polymer prodrug releasable in response to a redox environment. The polymer prodrug is a polymer prodrug obtained by linking heparin sodium to telmisartan by means of an esterification reaction of 2,2'-dithioethanol, said polymer prodru...
|
|
WO/2024/092211A1 |
The present disclosure provides for a polymer comprising repeating units of a cyclodextrin comprising α-cyclodextrin (α-CD), γ-cyclodextrin (γ-CD), or any combination thereof, and a crosslinker. Further provided herein are a particle...
|
|
WO/2024/089583A1 |
A derivative of tamarind seed polysaccharide (TSP) is disclosed, and a process for its preparation. In particular, said derivative is a sulphated TSP having a selected sulphation degree and molecular weight, showing improved workability,...
|
|
WO/2024/082045A1 |
The present invention relates to an integrated process for producing pectin and xylooligosaccharides from orange peel waste. The optimized extraction process using citric acid for producing pectin has been adapted for orange peel waste. ...
|
|
WO/2024/086087A2 |
Compositions and methods for treating and repairing nerve transections are provided.
|
|
WO/2024/080183A1 |
The glycan complex has a sugar chain to which a hydroxyapatite-binding molecule is bonded. The hydroxyapatite-binding molecule is at least one of an acidic peptide and estradiol.
|
|
WO/2024/076988A2 |
Provided are methods of attaching a mannose-binding C-type lectin receptor targeting moiety to a polymeric carbohydrate backbone using an amide linkage. The amide linkage may be found between a leash, such as an amine terminated leash, a...
|
|
WO/2024/076301A1 |
A colloidal suspension and method of forming the same There is provided a colloidal suspension comprising a biopolymer and a metal, wherein the ratio of the biopolymer to the metal is ≤ 1:50 by weight. There is also provided a method o...
|
|
WO/2024/073209A1 |
Synthesis of cationic-modified water-soluble polysaccharide is disclosed. The cation is pendent to the polysaccharide backbone. Chemical Mechanical Planarization (CMP) slurries comprise abrasives; activator; oxidizing agent; additive com...
|
|
WO/2024/071336A1 |
The present invention relates to a bacterial exopolysaccharide having a repeating structure comprising a series of repeating units represented by formula (I), and to the use of the bacterial exopolysaccharide for immunopotentiation. (In ...
|
|
WO/2024/072249A1 |
The present invention relates to a process for producing chitosan biopolymers characterised by comprising the steps of mechano-chemical extraction of chitin from biomass; and mechano- chemical deacetylation of chitin to chitosan, in whic...
|
|
WO/2024/073359A1 |
The present disclosure provides hydrophobically-modified biopolymers, including hydrophobically-modified chitosans, which comprise benzenediol groups, optionally where a portion are oxidized to the corresponding quinone. The biopolymers ...
|
|
WO/2024/066140A1 |
The present invention provides a method and system for simultaneously extracting Rosa roxburghii Tratt polysaccharide, Rosa roxburghii Tratt polyphenol, Rosa roxburghii Tratt SOD, and Vc from Rosa roxburghii Tratt pomace. The method comp...
|
|
WO/2024/063176A1 |
The present invention relates to a method for preparing a polylactic acid (PLA)-based composite plastic, a composite plastic prepared thereby, and a film comprising same. The present invention uses nanocellulose or chitin as a reinforcin...
|
|
WO/2024/061270A1 |
Disclosed in the present invention is a heparin pentasaccharide-based low molecular weight heparin mimetic, which is a heparin pentasaccharide dimer or heparin pentasaccharide trimer. Also disclosed in the present invention is a preparat...
|
|
WO/2024/062148A1 |
The present invention relates to a process for producing hemicellulose-derived products from a lignocellulose material, said process comprising an alkaline pretreatment of said lignocellulose material to produce a hydrolysable solid, and...
|
|
WO/2024/062494A1 |
The present invention broadly relates to the improved method for purification of capsular polysaccharides. Particularly, the present invention relates to the method of purification of capsular polysaccharides from Streptococcus pneumonia...
|
|
WO/2024/064359A2 |
Dual interpenetrating networks of physically-crosslinkable and ionically-crosslinkable marine polymers, where a physically-crosslinkable polymer is physically crosslinked in a manner than entrains an ionically-crosslinkable polymer, and ...
|
|
WO/2024/060946A1 |
The present invention belongs to the field of chemical materials and specifically relates to a preparation method for a low-molecular-weight chondroitin sulfate-iron. The specific technical scheme is the preparation method for the low-mo...
|
|
WO/2024/057083A1 |
The present invention generally relates to a process for the synthesis of selectively alkylated cyclodextrins. More particularly, the present invention relates to a process of cyclodextrin alkylation in a selective manner yielding hexaki...
|
|
WO/2024/056638A1 |
The present invention relates to a method for producing a stable hydrogel-cell composition comprising the steps of: a) providing a reaction mixture comprising at least one polymerizable substrate and at least one enzyme capable of polyme...
|
|
WO/2024/057154A1 |
The present invention describes a process for conjugating hyaluronic acid by using a specific condensing agent and under certain operating conditions which allow to obtain derivatives of hyaluronic acid with disaccharides or oligosacchar...
|
|
WO/2024/058255A1 |
The purpose of the present invention is to provide an agent for adjusting cytokine production by lipopolysaccharide derived from Escherichia coli, or an agent for adjusting TLR4 activation by lipopolysaccharide derived from Escherichia c...
|
|
WO/2024/055132A1 |
The present invention provides a method for the synthesis of a branched copolymer of hyaluronic acid (HA) and poly(lactic-co-glycolic acid) (PLGA), and the branched copolymer thus obtained (HA-g-PLGA). Said method comprises activating th...
|
|
WO/2024/056115A1 |
The present invention relates to a method for fabricating a composite based on natural Kondagogu gum polymer and MXene blend using environmentally friendly solvents and reagents. The obtained sustainable composite shows enhanced physicoc...
|
|
WO/2024/054682A2 |
Provided herein are heparin oligomers (e.g., heparin oligomers of Formula (I)), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs ther...
|
|
WO/2024/050647A1 |
A process for producing a high quality polyphenol-containing antioxidant extract from a seaweed biomass that yields a residual biomass available for alginate and fucoidan production.
|
|
WO/2024/053574A1 |
[Problem] The present invention addresses the problem of providing a novel oligosaccharide that is a two-branched glycan that has an α2,6-sialic acid structure at the non-reducing end, a production method for the oligosaccharide, an int...
|
|
WO/2024/053436A1 |
Provided is a cured product obtained by curing a composition containing: a monomer A having an ethylenically unsaturated group and a host group in a molecule thereof, wherein the host group is a monovalent group obtained by removing one ...
|
|
WO/2024/045207A1 |
The present invention relates to the technical field of polysaccharides. Disclosed are an auricularia auricula polysaccharide, use thereof, and a preparation method therefor. Auricularia auricula, after de-fatting, undergoes initial enzy...
|
|
WO/2024/050391A1 |
Disclosed herein are compositions and methods for the production of β-1,2-oligoglucans. Said compositions include glucose-1-phospahte, a primer molecule, and a β-glucan phosphorylase with β-1,2-glucan phosphorylase activity. For examp...
|
|
WO/2024/046048A1 |
The present invention relates to an anticoagulant heparin-derived oligosaccharide biphenyl dimer, and a preparation method therefor and a use thereof. The anticoagulant heparin-derived oligosaccharide biphenyl dimer has a structure as re...
|
|
WO/2024/043658A1 |
The present specification discloses a polymer composition. The polymer composition comprises a polysaccharide component, and the polysaccharide component comprises a radical polymeric functional group and a non-radical polymeric function...
|
|
WO/2024/040979A1 |
Provided is a vaccine adjuvant comprising ginseng acidic polysaccharide (GAPS), which can significantly improve the titer of a specific antibody (or a neutralizing antibody) after antigen immunization and can effectively enhance the immu...
|
|
WO/2024/042228A1 |
The disclosure relates to a synthetic method of producing delta-cyclodextrin. The method is scalable, and the isolation of the product does not require chromatography.
|
|
WO/2024/040480A1 |
The present invention relates to a gel material. The gel material is prepared by performing precrosslinking-low-temperature freezing crosslinking on endogenous polyamine and a hyaluronic acid substance under the action of an activating a...
|
|
WO/2024/038936A1 |
The present invention relates to a cross-linked copolymer, a preparation method thereof, and a patch comprising same. The cross-linked copolymer inhibits the activity of 5α-reductase and promotes hair growth, and thus can be used for pr...
|
|
WO/2024/036637A1 |
The present invention relates to the field of biochemistry, and specifically to a preparation method for a sodium hyaluronate oligosaccharide composition. Further disclosed are a prepared composition and a use. The preparation method for...
|
|
WO/2024/036399A1 |
The present application includes a composition comprising manno- oligosaccharide (MOS) carbohydrates for use in inhibiting growth of pathogenic bacteria and/or promoting growth of beneficial bacteria in a subject, wherein at least 70% wt...
|
|
WO/2024/038782A1 |
[Problem] To develop an elastic biomaterial (in particular, elastic collagen). [Solution] A method for producing a polyrotaxane containing a cyclic molecule having an aldehyde group added thereto, said method being capable of specificall...
|
|
WO/2024/038937A1 |
The present invention relates to a double cross-linked copolymer, a preparation method therefor and a patch comprising same. The double cross-linked copolymer has the ability to inhibit the activity of 5α-reductase and the effect of pro...
|
|
WO/2024/040035A2 |
Multifunctional hydrogels and methods of use thereof are provided.
|
|
WO/2024/038783A1 |
[Problem] The present invention addresses the problem of developing a stretchable biomaterial (in particular, a stretchable collagen). [Solution] The present inventors: found a method for producing a polyrotaxane comprising a cyclic mole...
|
|
WO/2024/032575A1 |
A heparin dodecasaccharide containing a double antithrombin binding sequence, a preparation method therefor, and use thereof. The heparin dodecasaccharide has a structure represented by formula I. Further provided are a chemoenzymatic pr...
|
